Immunovant, Inc.
IMVT
$22.71
$0.693.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -126.50M | -120.61M | -106.45M | -111.12M | -109.12M |
| Total Depreciation and Amortization | 105.00K | 107.00K | 109.00K | 99.00K | 89.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.38M | 18.53M | 11.71M | 11.68M | 12.72M |
| Change in Net Operating Assets | 10.50M | -15.44M | -16.01M | -1.04M | 7.67M |
| Cash from Operations | -102.52M | -117.41M | -110.64M | -100.39M | -88.65M |
| Capital Expenditure | -- | -- | -201.00K | -180.00K | -196.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -201.00K | -180.00K | -196.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.60M | 2.92M | 450.93M | 2.46M | 730.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -319.00K | -- | -- |
| Cash from Financing | 24.60M | 2.92M | 450.61M | 2.46M | 730.00K |
| Foreign Exchange rate Adjustments | 878.00K | -566.00K | -488.00K | -149.00K | 1.05M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.04M | -115.06M | 339.29M | -98.26M | -87.06M |